Concepedia

Elisabetta Antonioli

EA

Statistics

Publications

48

Citations

6.9K

H-Index

34

Active since

2003

Affiliations

University of Florence(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Bergamo

Ospedale San Bortolo

Azienda Ospedaliero-Universitaria Careggi

Elisabetta Antonioli is an author at University of Florence specializing in medicine, hematology, and hematopathology.

ORCID

Publications per year

2003–2023

48

Publications

48

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli et al. · Blood · 2007 · 653 citations

, , +11

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

Tiziano Barbui, Jüergen Thiele, Francesco Passamonti et al. · Journal of Clinical Oncology · 2011 · 538 citations · Full text

, , +17

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 515 citations · Full text

, , +17

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti et al. · Blood · 2011 · 447 citations · Full text

, , +17

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2007 · 444 citations

, , +10

1–5 of 48